Application of silencing insect autologous Hh gene in insect control
By identifying and silencing the Hh gene of the thrips in the flower thrips, using dsRNA technology to develop effective RNAi insecticides, solving the problem of scarcity of insecticidal target genes in RNAi technology, achieving efficient insect mortality rate, proving that this gene is an RNAi target It is highly lethal and effectively prevents and treats Tassoptera insects.
Patent Information
- Application Number
- CN202411265917.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-09-11
AI Technical Summary
In RNAi technology, there are not many genes to find suitable insecticide targets, which leads to the challenge of finding effective insecticides.
Effective RNAi insecticides were developed by identifying and silencing the Hh gene of insects, especially the Hh gene of Western thrips, using dsRNA technology to make it dead.
By silencing specific fragments of the thrips Hh gene of the flower-Sithis can achieve an insect mortality rate of more than 92.5% within 10 days, proving that this gene is highly lethal as an RNAi target and effectively prevents and treats Tassoptera insects.
Abstract
Description
Technical Field
[0001] The present invention relates to the field of insecticides, in particular to a dsRNA insecticide. Background Art
[0002] The gene silencing phenomenon caused by double-stranded RNA is called RNA interference (RNAi), and its mechanism of action is to achieve gene silencing by preventing the translation or transcription of homologous genes. When double-stranded RNA homologous to the endogenous mRNA coding region is introduced into the cell, the mRNA breaks and gene expression is silenced. The biggest feature of this technology is that it has strong specificity for target pests, will not harm any other organisms including natural enemies, does not change the genome of pests and insects, and will not affect the ecosystem. The main component used in RNAi technology is double-stranded RNA, which is ubiquitous in organisms and is easily degraded in the natural environment. Therefore, RNAi technology is non-toxic, residue-free, green and environmentally friendly, and has application prospects. RNAi pesticides and RNAi transgenic crops can be developed based on RNAi technology.
[0003] However, there are not many efficient insecticidal target genes for RNAi-based pest control, so finding suitable insecticidal targets is a very urgent task. Summary of the invention
[0004] One aspect of the present invention provides a dsRNA, wherein the sequence of the positive strand of the dsRNA is at least one of SEQ ID No. 4, SEQ ID No. 7 and SEQ ID No. 10.
[0005] The second aspect of the present invention provides the use of silencing an insect's own Hh gene for controlling the insect, wherein the insect is at least one of the Thripidae insects, wherein the insect's own Hh gene is silenced by using the dsRNA as described in one aspect of the present invention.
[0006] In one embodiment, the insect is occidentalis ( Frankliniella occidentalis ).
[0007] The third aspect of the present invention provides a nucleic acid, whose sequence is as shown in SEQ ID No. 1, or any sequence truncated from SEQ ID No. 1, and whose length is more than 400 bp.
[0008] In a specific embodiment, the sequence length of the nucleic acid is greater than 400 bp and less than 1350 bp.
[0009] In a specific embodiment, the sequence length of the nucleic acid is greater than 400 bp and less than 1200 bp.
[0010] In a specific embodiment, the sequence length of the nucleic acid is more than 400 bp and less than 800 bp. For example, the sequence of the nucleic acid can be a sequence amplified using the nucleic acid shown in SEQ ID No. 1 as a template and FoHh-F1 (SEQ ID NO. 2) and FoHh-R2 (SEQ ID No. 6) as primers.
[0011] In a specific embodiment, the sequence of the nucleic acid is at least one of SEQ ID No. 1, SEQ ID No. 4, SEQ ID No. 7 and SEQ ID No. 10.
[0012] It should be pointed out that it is well known to those skilled in the art that for dsRNA, t in each sequence needs to be replaced by u. However, for the sake of simplicity, the complete sequence in which t is replaced by u is no longer listed separately in the present invention.
[0013] Beneficial effects of the present invention: The present invention first discovered that silencing the self-Hh gene of insects can cause insect death, especially, for example, in silencing the fragment of more than 411 bp in the region of positions 128 to 538 of the gene in western flower thrips, the insect mortality rate can reach more than 92.5% on the 10th day, the fragment of more than 408 bp in the region of positions 516 to 923 can cause the insect mortality rate to reach more than 98.75% on the 10th day, and the fragment of more than 406 bp in the region of positions 910 to 1315 can cause the insect mortality rate to reach more than 86.25% on the 10th day. In short, the purpose of controlling insects, especially Thysanoptera insects, can be achieved by RNAi preparations and RNAi transgenic plants for silencing Hh genes. DETAILED DESCRIPTION
[0014] The above contents of the present invention are further described in detail below in the form of preferred implementation cases, but they do not constitute a limitation to the present invention.
[0015] Unless otherwise specified, the reagents in the embodiments of the present invention can be purchased through commercial channels.
[0016] Insects and tissue collection: Frankliniella occidentalis was reared on green beans in an artificial incubator at a temperature of (26 ± 1) °C, a relative humidity of 70% ± 7%, and a light intensity of 16:8 (L:D).
[0017] Bioinformatics analysis of genes: Bioinformatics techniques and software were used to conduct a preliminary analysis of the transcriptome data of western flower thrips, and the sequence of western flower thrips as shown in SEQ ID No. 1 was screened out, which was tentatively named Hh gene.
[0018] RNA extraction: Total RNA was extracted from the whole adult of western flower thrips using Trizol reagent (30 adults: 1 mL Trizol), and then dissolved in RNase-free H2O. 1 μl of the sample was diluted to 5 μl, of which 2.5 μl was used for electrophoresis detection and 2.5 μl was detected by NanoDrop instrument; the remaining RNA was used for cDNA synthesis or stored in a −70°C refrigerator.
[0019] Synthesis of first-strand cDNA: The entire reverse transcription process was carried out under RNase-free conditions, and cDNA was synthesized according to the operating procedures of the Revert Aid First Strand cDNA Synthesis Kit for subsequent dsRNA synthesis.
[0020] Synthesis of dsRNA: Three truncated interference target fragments, FoHh1, FoHh2 and FoHh3, were selected from the Hh gene of western flower thrips for subsequent cloning and dsRNA synthesis.
[0021] Primer design for amplifying FoHh1, FoHh2 and FoHh3 fragments: According to the CDS sequence of the Hh gene of western flower thrips (as shown in SEQ ID No. 1), the upstream primer FoHh-F1 (SEQ ID NO. 2) and the downstream primer FoHh-R1 (SEQ ID NO. 3) of the 128th to 538th position (FoHh1) of the gene of western flower thrips were designed using Primer Premier 5.0 software for PCR amplification of the FoHh1 fragment (SEQ ID NO. 4); the upstream primer FoHh-F2 (SEQ ID No. 5) and the downstream primer FoHh-R2 (SEQ ID No. 6) of the 516th to 923rd position (FoHh2) of the gene of western flower thrips were used for PCR amplification of the FoHh2 fragment (SEQ ID No. 7); the upstream primer FoHh-F3 (SEQ ID No. 6) of the 910th to 1315th position (FoHh3) of the gene of western flower thrips were used for PCR amplification of the FoHh2 fragment (SEQ ID No. 8). ID No. 8) and downstream primer FoHh-R3 (SEQ ID No. 9) were used to PCR amplify the FoHh3 fragment (SEQ ID No. 10).
[0022] PCR amplification, sequencing and sequence analysis of fragments FoHh1, FoHh2 and FoHh3: Using the synthesized cDNA as template, FoHh-F1 / R1, FoHh-F2 / R2 or FoHh-F3 / R3 as primer pairs, Prime Star enzyme PCR was used to amplify FoHh1, FoHh2 and FoHh3 fragments respectively. PCR products were detected by 1% agarose gel (prepared with 1×TAE buffer) electrophoresis. After detecting that the PCR product is correct, it is recovered using an agarose gel recovery kit (the operating steps are carried out according to the instructions included in the kit), the recovered FoHh1, FoHh2 and FoHh3 PCR fragments are respectively connected to the Blunt vector (the operating steps are carried out according to the instructions included in the kit), the ligation system is transformed into DH5α competent cells (the transformation steps are carried out according to the instructions included in the competent cells), a single colony is picked for plasmid recovery and then sent to a sequencing company for sequencing, and after identification, the positive Blunt-FoHh1 recombinant plasmid (containing the FoHh1 fragment), the positive Blunt-FoHh2 recombinant plasmid (containing the FoHh2 fragment) and the Blunt-FoHh3 recombinant plasmid (containing the FoHh3 fragment) and the corresponding DH5α / Blunt-FoHh1, DH5α / Blunt-FoHh2 and DH5α / Blunt-FoHh3 recombinant strains are obtained.
[0023] Preparation of FoHh1 dsRNA, FoHh2 dsRNA or FoHh2 dsRNA template: Using Blunt-FoHh1, Blunt-FoHh2 and Blunt-FoHh3 recombinant plasmids as templates, respectively, amplify the dsRNA template of FoHh1, FoHh2 or FoHh3 with polymerase. The upstream primer FoHhds-F1 for amplifying the FoHh1 dsRNA template consists of T7 promoter (SEQ ID No. 11) + FoHh-F1, and the downstream primer FoHhds-R1 consists of T7 promoter (SEQ ID No. 11) + FoHh-R1; the upstream primer FoHhds-F2 for amplifying the FoHh2 dsRNA template consists of T7 promoter (SEQ ID No. 11) + FoHh-F2, and the downstream primer FoHhds-R2 consists of T7 promoter (SEQ ID No. 11) + FoHh-R2; the upstream primer FoHhds-F3 for amplifying the FoHh3 dsRNA template consists of T7 promoter (SEQ ID No. 11) + FoHh-F3, and the downstream primer FoHhds-R3 consists of T7 promoter (SEQ ID No. 11) + FoHh- No.11)+FoHh-R3.
[0024] 1 μl of PCR product was tested by 1% agarose gel (prepared with 1×TAE buffer) electrophoresis. If the length of the obtained band is consistent with the length of the target fragment and the result shows a single bright band, it can be used as a template for the target dsRNA, and then the remaining PCR product was extracted and purified by phenol chloroform. The purified product was dissolved in 4 μl of RNase-free H2O, and the concentration and OD value were detected by a concentration measuring instrument. The product was tested for its uniformity by gel electrophoresis. If the detected band is a single bright band and its OD value is: 260 / 280: 1.8-2.0; 260 / 230: 1.8-2.0, it means that the PCR product is of good quality and can be used as a template for the next step of synthesizing dsRNA.
[0025] Synthesis of FoHh1 dsRNA, FoHh2 dsRNA or FoHh3 dsRNA: a) Place ATP, CTP, GTP, and UTP (all 100 mM) on ice and slowly melt them. Melt 5× reverse transcription buffer at room temperature. Store T7 RNA polymerase at -20 degrees Celsius. Take it out as needed and store it at -20 degrees Celsius immediately after use. After the dsRNA template melts, flick the bottom of the tube and centrifuge it to the bottom of the tube. b) Mix the reagents in the following proportions: 10 μl of transcription buffer, 1 μl each of 100 mM ATP, 100 mM CTP, 100 mM GTP and 100 mM UT, 1.25 μl of RNase inhibitor, 1.5 μg of FoHh1 dsRNA template or FoHh2 dsRNA template or FoHh3 dsRNA template, 1 μl of T7 RNA transcriptase, and finally adjust the volume to 50 μl with DEPC H2O. Flick to mix and centrifuge briefly. Place in a 37°C metal bath for 4 hours to obtain FoHh1 dsRNA, FoHh2 dsRNA and FoHh3 dsRNA synthesis products, respectively. c) Remove the centrifuge tube from the metal bath, place in a 75°C metal bath for 5 minutes, and then cool at room temperature (do not place on ice). Aspirate 1 μl, dilute 5 times, and detect product bands by gel electrophoresis. d) To remove DNA and ssRNA from the synthetic products of FoHh1 dsRNA, FoHh2 dsRNA or FoHh3 dsRNA, add the following reagents in proportion: 50 μL of the synthetic products of FoHh1 dsRNA, FoHh2 dsRNA or FoHh3 dsRNA, 10× reaction buffer, 2 μL of DNase I, 0.5 μL of RNase, and 1.5 μL of DEPC H2O. Mix thoroughly, flick the bottom of the tube, centrifuge briefly, place in a metal bath at 37 degrees Celsius for 30 minutes, add 1 μL of EDTA reagent, and place in a metal bath at 65 degrees Celsius for 5 minutes to terminate the reaction. Take 1 μL of the product, dilute it 5 times, and detect the homogeneity of the product by gel electrophoresis. The concentration and OD value are detected by a concentration detection instrument. If the detection band is a single bright band, and its OD value is: 260 / 280: 1.8-2.0, 260 / 230: 1.8-2.0, it means that the dsRNA is of good quality, and then the dsRNA is extracted with phenol chloroform. Use RNase-free H2O to flick the bottom of the tube to allow the precipitate to be fully and evenly dissolved in RNase-free H2O; take 1 microliter of the purified FoHh1 dsRNA, FoHh2 dsRNA or FoHh3 dsRNA product dissolved separately and dilute it in 4 microliters of DEPC H2O, use gel electrophoresis to detect the singleness of the product, and use a concentration detection instrument to detect the concentration and OD value.If the detected band is a single bright band and its OD value is: 260 / 280: 1.8 to 2.0, 260 / 230: 1.8 to 2.0, it proves that the FoHh1 dsRNA, FoHh2 dsRNA or FoHh3 dsRNA is of good quality and can be used for subsequent western flower thrips RNAi bioassay experiments.
[0026] The target fragment was replaced with enhanced green fluorescent protein (EGFP) gene and double-stranded EGFP dsRNA was prepared by the same operation.
[0027] RNAi bioassay experiment of western flower thrips: The western flower thrips selected for the bioassay in the present invention are 2nd instar nymphs, and the collection method of the 2nd instar nymphs is as follows.
[0028] Collect 50 to 100 adult flower thrips in a 150 mm culture dish, put clean filter paper and fresh green beans in the dish, transfer the adults to new green beans with a brush after about 70 hours, move the green beans fed with the adults to a new 150 mm culture dish, and new nymphs will be born after about 70 hours. Every 2 days, gently pick up the larvae with a soft brush and transfer them to new green beans. After 6 days, all the new nymphs grow into 2nd instar nymphs.
[0029] The feeding method simulates the process in which insects eat dsRNA residual on the surface of plants, dsRNA in bait, and dsRNA synthesized by plants in transgenic crops, and then dsRNA enters the insect body through the digestive system to exert insecticidal effects: the lethal effect of FoHh1, FoHh2 or FoHh3 is determined by feeding dsRNA with artificial feed. First, FoHh1 dsRNA, FoHh2 dsRNA or FoHh3 dsRNA with a final concentration of 200 ng / μl is evenly sprayed on the surface of new green beans with a nanosprayer, and then placed in a 150 mm culture dish, and healthy 2nd-instar nymphs of the same size are selected and gently transferred to the above culture dish with a small brush. Among them, the culture dish and green beans must be sterilized by ultraviolet in advance, and the entire bioassay operation must be carried out in a sterile environment. The culture dish is placed in an incubator at 26±1°C, 70±7% relative humidity and a photoperiod of 16:8 (L:D). Each feeding experiment used EGFP dsRNA at a final concentration of 200 ng / μl as a negative control, with 8 biological replicates (n=30 nymphs). The mortality rate at 10 days was counted. The results showed that after feeding with FoHh1 dsRNA, the mortality rate of western flower thrips was 92.5%; after feeding with FoHh2 dsRNA, the mortality rate of western flower thrips was 98.75%; after feeding with FoHh3 dsRNA, the mortality rate of western flower thrips was 86.25%; after feeding with EGFP dsRNA, the mortality rate of western flower thrips was 7.5%, and the three treatments of FoHh1 dsRNA, FoHh2 dsRNA, and FoHh3 dsRNA were significantly different from the control GFP dsRNA at the P<0.001 level, there was no significant difference between the FoHh1 dsRNA and FoHh2 dsRNA treatments, and there was a significant difference between the FoHh3 dsRNA treatment and the FoHh1 dsRNA and FoHh2 dsRNA treatments at the P<0.001 level.
[0030] The three fragments selected above are the front segment, middle segment and back segment of the Hh gene, respectively. The results show that the Hh gene (FoHh) of western flower thrips can be used as the target of RNAi to achieve a good insecticidal effect; in particular, the selection of FoHh1, FoHh2 and FoHh3 among them all achieved excellent insecticidal effects; especially FoHh1 and FoHh2.
Claims
1. A dsRNA, wherein the sequence of the positive strand of the dsRNA is at least one of SEQ ID No. 4, SEQ ID No. 7 and SEQ ID No.
10.
2. Application of silencing insect autologous Hh gene for controlling said insect, said insect being western flower thrips ( Frankliniella occidentalis ),in, The insect's own Hh gene is silenced by using the dsRNA according to claim 1.
